These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 27990610)

  • 61. Cell fate, metabolic reprogramming and lncRNA of tumor-initiating stem-like cells induced by alcohol.
    Machida K
    Chem Biol Interact; 2020 May; 323():109055. PubMed ID: 32171851
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Oncogenic signaling pathways and origins of tumor-initiating stem-like cells of hepatocellular carcinomas induced by hepatitis C virus, alcohol and/or obesity.
    Chen CL; Tsukamoto H; Machida K
    Hepatol Int; 2014 Jul; 8(3):330-8. PubMed ID: 26202636
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Human hepatic cancer stem cells are characterized by common stemness traits and diverse oncogenic pathways.
    Marquardt JU; Raggi C; Andersen JB; Seo D; Avital I; Geller D; Lee YH; Kitade M; Holczbauer A; Gillen MC; Conner EA; Factor VM; Thorgeirsson SS
    Hepatology; 2011 Sep; 54(3):1031-42. PubMed ID: 21618577
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The origin of cancer stem cells.
    Bu Y; Cao D
    Front Biosci (Schol Ed); 2012 Jan; 4(3):819-30. PubMed ID: 22202093
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The biology of cancer stem cells and its clinical implication in hepatocellular carcinoma.
    Yoon SK
    Gut Liver; 2012 Jan; 6(1):29-40. PubMed ID: 22375168
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Single-cell analysis reveals cancer stem cell heterogeneity in hepatocellular carcinoma.
    Zheng H; Pomyen Y; Hernandez MO; Li C; Livak F; Tang W; Dang H; Greten TF; Davis JL; Zhao Y; Mehta M; Levin Y; Shetty J; Tran B; Budhu A; Wang XW
    Hepatology; 2018 Jul; 68(1):127-140. PubMed ID: 29315726
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cancer Stem Cells in Hepatocellular Carcinoma.
    Yagci T; Cetin M; Ercin PB
    J Gastrointest Cancer; 2017 Sep; 48(3):241-245. PubMed ID: 28643126
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Impact of proteolysis on cancer stem cell functions.
    Hillebrand LE; Reinheckel T
    Biochimie; 2019 Nov; 166():214-222. PubMed ID: 30876968
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A Mathematical Model of Average Dynamics in a Stem Cell Hierarchy Suggests the Combinatorial Targeting of Cancer Stem Cells and Progenitor Cells as a Potential Strategy against Tumor Growth.
    Molina-Peña R; Tudon-Martinez JC; Aquines-Gutiérrez O
    Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32932755
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Fate and functional roles of Prominin 1
    Wu R; Pan S; Chen Y; Nakano Y; Li M; Balog S; Tsukamoto H
    Sci Rep; 2020 Nov; 10(1):19412. PubMed ID: 33173221
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Traditional Chinese medicine targeting cancer stem cells as an alternative treatment for hepatocellular carcinoma.
    Tang KY; Du SL; Wang QL; Zhang YF; Song HY
    J Integr Med; 2020 May; 18(3):196-202. PubMed ID: 32067923
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A case of small hepatocellular carcinoma with malignant ductular reaction.
    Iwasaki T; Kubota A; Suzuki M; Terada T
    Int J Clin Exp Pathol; 2020; 13(5):1073-1080. PubMed ID: 32509081
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Mechanisms of resistance to tyrosine kinase inhibitors in liver cancer stem cells and potential therapeutic approaches.
    Man KF; Ma S
    Essays Biochem; 2022 Sep; 66(4):371-386. PubMed ID: 35818992
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Stemness in Liver Cancer.
    Thorgeirsson SS
    Dig Dis; 2017; 35(4):387-389. PubMed ID: 28467999
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cancer Stem Cell Metabolism.
    Alvina FB; Gouw AM; Le A
    Adv Exp Med Biol; 2021; 1311():161-172. PubMed ID: 34014542
    [TBL] [Abstract][Full Text] [Related]  

  • 76. deSUMOylation signaling: a novel mechanism of liver CSC properties and hepatocarcinogenesis in hypoxia.
    Zhao H; Yao P; Fu N; Chen L
    Acta Biochim Biophys Sin (Shanghai); 2017 Dec; 49(12):1135-1137. PubMed ID: 29040348
    [No Abstract]   [Full Text] [Related]  

  • 77. Carcinogenetic initiation contributed by EpCAM+ cancer cells in orthotopic HCC models of immunocompetent and athymic mice.
    Pandit H; Li Y; Zheng Q; Guo W; Yu Y; Li S; Martin RCG
    Oncotarget; 2020 Jun; 11(22):2047-2060. PubMed ID: 32547703
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Immunotherapy and Microbiota for Targeting of Liver Tumor-Initiating Stem-like Cells.
    Machida K; Tahara SM
    Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35625986
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Interleukin-17 programs liver progenitor cell transformation into cancer stem cells through miR-122 downregulation with increased risk of primary liver cancer initiation.
    Gasmi I; Machou C; Rodrigues A; Brouillet A; Nguyen TC; Rousseau B; Guillot A; Rodriguez C; Demontant V; Ait-Ahmed Y; Calderaro J; Luciani A; Pawlotsky JM; Lafdil F
    Int J Biol Sci; 2022; 18(5):1944-1960. PubMed ID: 35342340
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Napabucasin Reduces Cancer Stem Cell Characteristics in Hepatocellular Carcinoma.
    Li Y; Han Q; Zhao H; Guo Q; Zhang J
    Front Pharmacol; 2020; 11():597520. PubMed ID: 33343368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.